BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3613649)

  • 1. An 8;14 translocation in a case of plasma cell leukemia.
    Copplestone JA; Oscier DG; Johnson S
    Leuk Res; 1987; 11(7):655-9. PubMed ID: 3613649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A 14q+ marker chromosome due to t(11;14) in a case of nonsecretory plasma cell leukemia].
    Fukushima Y; Miura I; Niitsu H; Hashimoto K; Takatsu H; Akihama T; Miura A
    Rinsho Ketsueki; 1986 Nov; 27(11):2124-30. PubMed ID: 3820630
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of primary malignant lymphoma of the rectum with chromosomal abnormality of t (8;14) (q24;q32)].
    Ono T; Ito R; Komatsu M; Goto M; Funaoka M; Ohshima S; Masamune O
    Nihon Shokakibyo Gakkai Zasshi; 1994 Aug; 91(8):1348-52. PubMed ID: 8089921
    [No Abstract]   [Full Text] [Related]  

  • 4. 2 translocations, t(11;14) and t(1;6), in a patient with plasma cell leukaemia and 2 populations of plasma cells.
    Gahrton G; Zech L; Nillsson K; Lönnqvist B; Carlström A
    Scand J Haematol; 1980 Jan; 24(1):42-6. PubMed ID: 7367830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary plasma cell leukemia with unusual morphology and complex karyotype.
    Panizo C; Cuesta B; Rocha E
    Haematologica; 1998 Sep; 83(9):849-50. PubMed ID: 9825580
    [No Abstract]   [Full Text] [Related]  

  • 6. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.
    Liu D; Shimonov J; Primanneni S; Lai Y; Ahmed T; Seiter K
    Mol Cancer; 2007 Jun; 6():35. PubMed ID: 17547754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin D1 in chronic lymphoproliferation with t(11; 14)(q13; q32).
    Takahashi T; Hayashi T; Minami T; Adachi M; Hinoda Y; Imai K
    Int J Hematol; 1997 Dec; 66(4):521-3. PubMed ID: 9479879
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromosome translocations in B and T cell neoplasias.
    Showe LC; Croce CM
    Semin Hematol; 1986 Oct; 23(4):237-44. PubMed ID: 3535082
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel three-way variant t(4;17;5)(p16;q23;q31) in a case of secondary plasma cell leukemia.
    Kim Y; Kim J; Park SJ; Choi JR; Lee KA; Kim YR
    Leuk Res; 2012 May; 36(5):e101-2. PubMed ID: 22317980
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
    Fonseca R; Hoyer JD; Aguayo P; Jalal SM; Ahmann GJ; Rajkumar SV; Witzig TE; Lacy MQ; Dispenzieri A; Gertz MA; Kyle RA; Greipp PR
    Leuk Lymphoma; 1999 Nov; 35(5-6):599-605. PubMed ID: 10609798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cell leukemia presenting with diplopia due to unilateral abducens paralysis and complex chromosomal abnormalities.
    Nakaya A; Ogihara T; Awaya N
    Intern Med; 2006; 45(9):637-40. PubMed ID: 16755096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Burkitt-type 8;14 translocation in a case of plasma cell leukemia.
    Yamada K; Shionoya S; Amano M; Imamura Y
    Cancer Genet Cytogenet; 1983 May; 9(1):67-70. PubMed ID: 6839308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar cytogenetic abnormalities in two cases of plasma cell leukemia.
    Smadja N; Krulik M; Louvet C; de Gramont A; Gonzalez-Canali G; Mougeot-Martin M
    Cancer Genet Cytogenet; 1991 Mar; 52(1):123-9. PubMed ID: 2009507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Plasma Cell Leukemia Associated with t(6;14)(p21;q32) and IGH Rearrangement: A Case Study and Review of the Literature.
    Cho SY; Lim G; Oh SH; Lee HJ; Suh JT; Lee J; Lee WI; Lee HG; Yoon HJ; Park TS
    Ann Clin Lab Sci; 2011; 41(3):277-81. PubMed ID: 22075513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations.
    Ji M; Jang S; Lee JH; Seo EJ
    Ann Hematol; 2013 Aug; 92(8):1129-31. PubMed ID: 23307601
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14).
    Gonsalves WI; Buadi FK; Kumar SK
    Eur J Haematol; 2018 Feb; 100(2):215-217. PubMed ID: 29064593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine.
    Scapinello G; Pizzi M; Vio S; Nabergoj M; Visentin A; Martines A; Bonaldi L; Trentin L; Semenzato G; Piazza F
    Ann Hematol; 2018 Oct; 97(10):2001-2003. PubMed ID: 29728736
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of a highly aberrant plasma cell leukemia karyotype: a case report.
    Heller A; Fricke HJ; Starke H; Loncarevic IF; Claussen U; Liehr T
    Oncol Rep; 2004 Jan; 11(1):89-92. PubMed ID: 14654908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocations involving 5q35 may also be associated with plasma cell leukemia.
    Maynadie M; Mugneret F; Guy H; Turc-Carel C
    Br J Haematol; 1990 Sep; 76(1):156. PubMed ID: 2223641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.